Navicare Biotech Co., Ltd. (TPEX:8472)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
74.20
-4.00 (-5.12%)
Sep 8, 2026, 1:30 PM CST

Navicare Biotech Market Cap

Navicare Biotech has a market cap or net worth of 1.32 billion as of September 4, 2026. Its market cap has decreased by -8.14% in one year.

Market Cap
1.32B
Enterprise Value
1.47B
Revenue
505.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
74.20

Chart

Chart

Since January 14, 2015, Navicare Biotech's market cap has decreased from 3.63B to 1.32B, a decrease of -63.61%. That is a compound annual growth rate of -8.31%.

History

DateMarket Cap% Change
Sep 8, 20261.32B4.49%
Dec 31, 20251.26B174.23%
Dec 31, 2024461.13M-31.13%
Dec 29, 2023669.53M-10.12%
Dec 30, 2022744.90M-16.83%
Dec 30, 2021895.66M-24.85%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding